Methods for Causality Assessment of Adverse Drug Reactions

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Drug Safety

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.2165/00002018-200831010-00003PMID 18095744
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Proposal for a New Tool to Evaluate Drug Interaction Cases

  2007cited by this paper
• A new method for assessing drug causation provided agreement with experts' judgment.

  2006cited by this paper
• Are the Naranjo Criteria Reliable and Valid for Determination of Adverse Drug Reactions in the Intensive Care Unit?

  2005cited by this paper
• Causality assessment of adverse drug reactions: comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panel

  2005cited by this paper
• A New Algorithm to Identify the Causality of Adverse Drug Reactions

  2005cited by this paper
• Agreement of expert judgment in causality assessment of adverse drug reactions

  2005cited by this paper
• Clarification of Terminology in Drug Safety

  2005cited by this paper
• Adverse drug reactions: physicians' opinions versus a causality assessment method

  2004cited by this paper
• Causality assessment of adverse drug reactions: comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panel, according to different levels of imputability

  2003cited by this paper
• The Quality of Published Adverse Drug Event Reports

  2003cited by this paper
• Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study

  2002cited by this paper
• Reporting of fatal adverse drug reactions.

  2001cited by this paper
• Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies.

  1998cited by this paper
• Causality assessment revisited

  1998cited by this paper
• Development and validation of a clinical scale for the diagnosis of drug‐induced hepatitis

  1997cited by this paper
• Algorithms Used in Adverse Drug Event Reports: A Comparative Study

  1997cited by this paper
• Causal or Casual?

  1997cited by this paper
• Computerized Bayesian Evaluation of Adverse Events

  1995cited by this paper
• Computer‐Assisted Evaluation of Adverse Events Using a Bayesian Approach

  1994cited by this paper
• Enhanced differential diagnosis of anticonvulsant hypersensitivity reactions by an integrated Bayesian and biochemical approach

  1994cited by this paper
• Causality Assessment of Adverse Events in Clinical Trials: II. An Algorithm for Drug Causality Assessment

  1993cited by this paper
• Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries.

  1993cited by this paper
• Causality assessment of adverse reactions to drugs--II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge.

  1993cited by this paper
• Drug-related emergency department visits and hospital admissions.

  1992cited by this paper
• Causality Assessment in the European Pharmaceutical Industry: Presentation of the Preliminary Results of a New Method

  1992cited by this paper
• A Consultant's View on the Role of Bayesian Differential Diagnosis in the Safety Assessment of Pharmaceuticals

  1992cited by this paper
• Causality assessment of adverse drug reactions using decision support and informatics tools

  1992cited by this paper
• Recognition and assessment of adverse drug reactions in children.

  1991cited by this paper
• Computerized Aids for Probabilistic Assessment of Drug Safety I: A Spreadsheet Program*

  1991cited by this paper
• Computerized Bayesian ADE Assessment

  1991cited by this paper
• Adverse drug reactions: scope and limitations of causality assessment and the use of algorithms

  1991cited by this paper
• The Bayesian Differential Diagnosis of Neutropenia Associated with Antiarrhythmic Agents

  1990cited by this paper
• A Bayesian Assessment of Idiosyncratic Adverse Reactions to New Drugs: Guillain‐Barré Syndrome and Zimeldine

  1990cited by this paper
• Criteria of drug-induced liver disorders. Report of an international consensus meeting.

  1990cited by this paper
• Assessing methods for causality assessment of suspected adverse drug reactions.

  1989cited by this paper
• Prediction of risk for pseudoallergic reactions and histamine release in patients undergoing anaesthesia and surgery: A computer-aided model using independence-Bayes

  1988cited by this paper
• The causality assessment of adverse drug reactions using a bayesian approach

  1987cited by this paper
• The diagnosis of adverse medical events associated with drug treatment.

  1987cited by this paper
• Computerized comparison of six adverse drug reaction assessment procedures

  1986cited by this paper
• Imputabilité d'un effet tératogène.

  1986cited by this paper
• Comparison of three algorithms used to evaluate adverse drug reactions.

  1986cited by this paper
• Assessing Causality of Adverse Drug Reactions: Global Introspection and Its Limitations

  1986cited by this paper
• [Imputability of a teratogenic effect].

  1986cited by this paper
• Updating of a method for causality assessment of adverse drug reactions.

  1986cited by this paper
• Imputabilité des effets inattendus ou toxiques des médicaments: actualisation de la méthode utilisée en France

  1985cited by this paper
• [Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France].

  1985cited by this paper
• Drug-induced Hepatic Injury

  1985cited by this paper
• Assessment of Causality in Industrial Settings

  1984cited by this paper
• Assessment of Causality in Industrial Setting Special Workshop—Industrial

  1984cited by this paper
• Aspects of Standardization as Applied to the Assessment of Drug-Event Associations Keynote Address

  1984cited by this paper
• The Food and Drug Administration Algorithm: Special Workshop—Regulatory

  1984cited by this paper
• Standardized Assessment of Adverse Drug Reactions: The Method Used in France Special Workshop—Clinical

  1984cited by this paper
• The Australian Method of Drug-Event Assessment Special Workshop—Regulatory

  1984cited by this paper
• The Swedish Drug-Event Assessment Methods Special Workshop—Regulatory

  1984cited by this paper
• [Imputability in drug monitoring. Principles of the balanced drug reaction assessment method and principal errors to avoid].

  1983cited by this paper
• Reasons for disagreement in the standardized assessment of suspected adverse drug reactions

  1983cited by this paper
• [Evaluation of the documentation on adverse effects of drugs. Proposition. 2. Imputability].

  1982cited by this paper
• Adverse drug reactions in the community health setting: approaches to recognizing, counseling, and reporting.

  1982cited by this paper
• Comparison of two recently published algorithms for assessing the probability of adverse drug reactions.

  1982cited by this paper
• A method for estimating the probability of adverse drug reactions

  1981cited by this paper
• An algorithm for the classification of untoward events in large scale clinical trials.

  1980cited by this paper
• Standardized assessment of drug-adverse reaction associations--rationale and experience.

  1980cited by this paper
• An algorithm for the operational assessment of adverse drug reactions. II. Demonstration of reproducibility and validity.

  1979cited by this paper
• Judgments of trained observers on adverse drug reactions

  1979cited by this paper
• An algorithm for the operational assessment of adverse drug reactions. III. Results of tests among clinicians.

  1979cited by this paper
• An algorithm for the operational assessment of adverse drug reactions. I. Background, description, and instructions for use.

  1979cited by this paper
• [Mehtod for determination of undesirable effects of drugs].

  1978cited by this paper
• The ambiguity of adverse drug reactions

  1977cited by this paper
• Toward the operational identification of adverse drug reactions

  1977cited by this paper
• Teaching monograph. Tissue reactions to drugs.

  1976cited by this paper
• Adverse drug reactions—a matter of opinion

  1976cited by this paper
• Teaching monograph. Tissue reactions to drugs.

  1976cited by this paper
• Adverse drug reactions. A critical review.

  1975cited by this paper
• Adverse drug reactions. A critical review.

  1975cited by this paper
• The Environment and Disease: Association or Causation?

  1965cited by this paper

• Portability of a text mining algorithm for detecting adverse drug reactions in electronic health records across diverse patient groups in two Dutch hospitals

  2026cites this paper
• Interplay of Spontaneous Reporting and Longitudinal Healthcare Databases for Signal Management: Position Statement from the Real-World Evidence and Big Data Special Interest Group of the International Society of Pharmacovigilance

  2025cites this paper
• Interactions Between Direct Oral Anticoagulants and Drugs Involving CYP-Enzymes and P-gp Transporters Detected by a Clinical Decision Support System: A Retrospective Cohort Study

  2025cites this paper
• Leveraging Large Language Models in Extracting Drug Safety Information from Prescription Drug Labels

  2025cites this paper
• Causality, severity, seriousness, and preventability of adverse drug reactions: A retrospective analysis

  2025cites this paper
• ÇOCUKLARDA AKILCI ANTİBİYOTİK KULLANIMINDA FARMAKOVİJİLANSIN ÖNEMİ

  2025cites this paper
• Agreement and correlation between WHO-UMC Causality scale and the Naranjo algorithm for causality assessment of adverse drug reactions at tertiary care center in Northern India

  2025cites this paper
• Description of the Properties of an Herbal Admixture (BabySed) During Trans‐Thoracic Echocardiography in Children Under Six Years Old, and Comparison to Chloral Hydrate

  2025cites this paper
• Advocating for a community-centred model for responding to potential information harms

  2025cites this paper
• Diagnosis and treatment of a patient with severe hepatitis and rash caused by toripalimab: A case report

  2025cites this paper
• Causality Assessment of Adverse Events by Healthcare Professionals in an Academic Hospital Setting: A Descriptive Retrospective Study.

  2025cites this paper
• Artificial intelligence in pharmacovigilance: a narrative review and practical experience with an expert-defined Bayesian network tool

  2025cites this paper
• Analysis of clinical characteristics of tislelizumab-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in the Chinese population: a systematic review

  2025cites this paper
• Quality of Clinical Information in Pregnancy Pharmacovigilance Data Sources—A Contribution of the ConcePTION Project

  2025cites this paper
• Deduplicating the FDA adverse event reporting system with a novel application of network-based grouping

  2025cites this paper
• A retrospective analysis of spontaneous reports of suspected adverse drug reactions to triptorelin acetate in a tertiary pediatric medical center: still a lot of preventable harm

  2025cites this paper
• Navigating Drug Safety Efficacy at Hospitals in Kerala: A Review of Pharmacovigilance Practices Critical Global Strategy for Drug Safety Monitoring

  2025cites this paper
• A real-world drug safety surveillance study from the FAERS database of hepatocellular carcinoma patients receiving durvalumab in combination with tremelimumab

  2025cites this paper
• A real-world safety evaluation of new oral anticoagulants in elderly patients: evidence from the Adverse Drug Reaction Monitoring Center of Henan Province

  2025cites this paper
• Beyond black boxes: using explainable causal artificial intelligence to separate signal from noise in pharmacovigilance.

  2025cites this paper
• Comparison of the Completeness of Spontaneously Reported Adverse Drug Reactions by Consumers, Healthcare Professionals, and Pharmaceutical Companies: An Evaluation of Databases From Two High‐Income Countries

  2025cites this paper
• The Association of Dementia With Incident Adverse Drug Reactions in Hospitalized Older Adults.

  2024cites this paper
• Trust but Verify: Lessons Learned for the Application of AI to Case-Based Clinical Decision-Making From Postmarketing Drug Safety Assessment at the US Food and Drug Administration

  2024cites this paper
• Tree‐temporal scan statistics for safety signal detection in vaccine clinical trials

  2024cites this paper
• Causality, Severity, Preventability and Predictability Assessments Scales for Adverse Drug Reactions: A Review

  2024influential citation
• A retrospective study of the efficacy and safety of levofloxacin in children with severe infection

  2024cites this paper
• Inter-rater agreement between WHO- Uppsala Monitoring Centre system and Naranjo algorithm for causality assessment of adverse drug reactions.

  2024cites this paper
• Rash caused by lurasidone in old chinese patient with bipolar disorder: case-based review

  2024cites this paper
• Why Don’t We Adequately Identify and Manage Adverse Drug Reactions despite Having the Needed Information?

  2024cites this paper
• Comparison of WHO-UMC and Naranjo Scales for Causality Assessment of Reported Adverse Drug Reactions

  2024cites this paper
• ID Consultant: Laboratory monitoring during long-term use of oral antimicrobials in pediatric patients.

  2024cites this paper
• Artificial intelligence in pharmacovigilance – Opportunities and challenges

  2024cites this paper
• Development of a text mining algorithm for identifying adverse drug reactions in electronic health records

  2024cites this paper
• A Narrative Review on Evaluation of Causal Drug in Cutaneous Drug Eruptions: Challenges, Current State, and the Path Ahead

  2024cites this paper
• Acute aseptic meningitis temporally associated with trimethoprim and sulfamethoxazole: Systematic review

  2024cites this paper
• Review on Artificial Intelligence in Pharmacovigilance: Opportunities and Challenges

  2024cites this paper
• Algorithmovigilance, lessons from pharmacovigilance

  2024cites this paper
• Common adverse events of herbal formulas for developing reporting forms for clinical practice and research: An overview of systematic reviews

  2024cites this paper
• Graph neural network-based subgraph analysis for predicting adverse drug events

  2024cites this paper
• Virus-Induced Epilepsy vs. Epilepsy Patients Acquiring Viral Infection: Unravelling the Complex Relationship for Precision Treatment

  2024cites this paper
• A scoping review of the clinical utility of adverse drug reaction causality analysis tools for use in the hospital setting

  2024influential citation
• Medication-related harm (MRH) in Egyptian older adults post-hospital discharge: a health-care challenge

  2024cites this paper
• The International Working Group on New Developments in Pharmacovigilance: Advancing Methods and Communication in Pharmacovigilance.

  2024cites this paper
• Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems

  2024cites this paper
• Survey on biomarkers in human vocalizations

  2024cites this paper
• Causality Assessment Between Drugs and Fatal Cerebral Haemorrhage Using Electronic Medical Records: Comparative Evaluation of Disease-Specific and Conventional Methods

  2024cites this paper
• Immune checkpoint inhibitor–associated capillary leak syndrome: A systematic review and a worldwide pharmacovigilance study

  2023cites this paper
• Important Considerations for Signal Detection and Evaluation

  2023cites this paper
• Causality assessment of adverse drug reactions in neonates: a comparative study between Naranjo's algorithm and Du's tool

  2023cites this paper
• Does a steroid dementia syndrome really exist? A brief narrative review of what the literature highlights about the relationship between glucocorticoids and cognition

  2023cites this paper
• Recurring Fatigue After Biologic Administration: Patient-Reported Data from the Dutch Biologic Monitor

  2023cites this paper
• In-vitro detection of suspected drug in maculopapular drug reaction to antibiotics using secreted cytokines from drug-specific activated T cells.

  2023cites this paper
• Intensive care drug therapy and its potential adverse effects on blood pressure and heart rate in critically ill children

  2023cites this paper
• Omissions, Ambiguities, and Underuse of Causal Assessment Tools: a Systematic Review of Case Reports on Patients Who Use Kratom

  2023cites this paper
• Adverse drug reactions in an ageing PopulaTion (ADAPT) study: Prevalence and risk factors associated with adverse drug reaction-related hospital admissions in older patients

  2023cites this paper
• Aspects to consider in causality assessment of safety signals: broadening the thought process

  2023cites this paper
• Navigating Drug-Induced Adversities: A Python-Based Console Application for Causality Assessment Using the Naranjo Algorithm

  2023cites this paper
• Pharmacovigilance: Need for Indian Pharma Industry

  2023cites this paper
• Bidirectional Encoder Representations from Transformers-like large language models in patient safety and pharmacovigilance: A comprehensive assessment of causal inference implications

  2023cites this paper
• Causality assessment of adverse drug reaction: A narrative review to find the most exhaustive and easy-to-use tool in post-authorization settings.

  2023cites this paper
• Oral isotretinoin and sacroiliitis: causal link or coincidence? Discussion points emerging from a case-based review

  2022cites this paper
• Quality of Spontaneous Reports of Adverse Drug Reactions Sent to a Regional Pharmacovigilance Unit

  2022cites this paper
• Prevalence of iatrogenic CNS inflammation at a tertiary neuroimmunology clinic.

  2022cites this paper
• Nonsteroidal anti-inflammatory drug exposure and the risk of microscopic colitis

  2022cites this paper
• An Overview of Pharmacovigilance: A key for Drug Safety and Monitoring

  2022cites this paper
• Actual drug-related harms in residential aged care facilities: a narrative review

  2022cites this paper
• Recurrent pneumothorax in a patient with liposarcoma as either a complication of lung micrometastasis or a potential adverse event from antibiotic therapy: A case report

  2022cites this paper
• A RETROSPECTIVE STUDY: ANALYSIS OF ADVERSE DRUG REACTION IN PEDIATRIC PATIENTS IN A TERTIARY CARE HOSPITAL

  2022cites this paper
• Toward Kidney-Specific Causality Assessment Tool.

  2022cites this paper
• Drug-related hospital admissions in older adults: comparison of the Naranjo algorithm and an adjusted version of the Kramer algorithm

  2022cites this paper
• Medication-related Medical Emergency Team activations: a case review study of frequency and preventability

  2022cites this paper
• “Artificial Intelligence” for Pharmacovigilance: Ready for Prime Time?

  2022cites this paper
• Lab-Based Culprit Drug Identification Methods for Cutaneous Drug Eruptions: A Scoping Review

  2022cites this paper
• Comparison of the MOdified NARanjo Causality Scale (MONARCSi) for Individual Case Safety Reports vs. a Reference Standard

  2022cites this paper
• Self-perceived versus physician documented adverse events in patients with multiple sclerosis REGIMS-a pharmacovigilance registry for patients with multiple sclerosis in Germany.

  2022cites this paper
• Shortcomings of Administrative Data to Derive Preventive Strategies for Inhospital Drug-Induced Acute Kidney Failure—Insights from Patient Record Analysis

  2022cites this paper
• Performance of a trigger tool for detecting adverse drug reactions in patients with polypharmacy acutely admitted to the geriatric ward

  2022cites this paper
• Sports nutrition supplements and adverse events – a meta-epidemiological study of case reports specifically addressing causality assessment

  2021cites this paper
• Agreement between WHO-UMC causality scale and the Naranjo algorithm for causality assessment of adverse drug reactions

  2021cites this paper
• Improving the data quality of spontaneous ADR reports: a practical example from Malta

  2021cites this paper
• Evaluating safety and toxicity

  2021cites this paper
• Effectiveness of the application of an electronic medication management support system in patients with polypharmacy in general practice: a study protocol of cluster-randomised controlled trial (AdAM)

  2021cites this paper
• Knowledge and Perception of Pharmacy Practice Students on Causality Assessment of Adverse Drug Reactions

  2021cites this paper
• The Transporter-Mediated Cellular Uptake and Efflux of Pharmaceutical Drugs and Biotechnology Products: How and Why Phospholipid Bilayer Transport Is Negligible in Real Biomembranes

  2021cites this paper
• Agreement among different scales for causality assessment in drug-induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

  2021cites this paper
• Feature engineering and machine learning for causality assessment in pharmacovigilance: Lessons learned from application to the FDA Adverse Event Reporting System

  2021cites this paper
• Defining and Measuring Meditation-Related Adverse Effects in Mindfulness-Based Programs

  2021cites this paper
• Assessing causality by means of the Naranjo scale in a paediatric patient with life threatening respiratory failure after alemtuzumab administration: a case report

  2021cites this paper
• Methods for Identifying Culprit Drugs in Cutaneous Drug Eruptions: A Scoping Review

  2021cites this paper
• Mapping of drug-related problems among older adults conciliating medical and pharmaceutical approaches

  2021cites this paper
• Rheumatic Immuno-related Adverse Events following Immunotherapy with Checkpoint Inhibitors: Adverse Drug Reaction, or Other?

  2021cites this paper
• Causality assessment between reported fatal cerebral haemorrhage and suspected drugs: developing a new algorithm based on the analysis of the Japanese Adverse Event Report (JADER) database and literature review

  2021cites this paper
• Lamotrigine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Singapore: A case series.

  2021cites this paper
• Nobody ever questions—Polypharmacy in care homes: A mixed methods evaluation of a multidisciplinary medicines optimisation initiative

  2021cites this paper
• Agreement between a regional pharmacovigilance centre and an adjudication committee regarding drug adverse reactions on a cohort of hospitalised children.

  2021cites this paper
• An unusual presentation of pemphigus foliaceus following COVID‐19 vaccination

  2021cites this paper
• Assessing Causality from Case Reports

  2021cites this paper
• Identifying adverse drug reactions from free‐text electronic hospital health record notes

  2021cites this paper
• Adverse Drug Reactions at Nonelective Hospital Admission in Children and Adolescents: Comparison of 4 Causality Assessment Methods

  2021cites this paper
• Validation of a novel causality assessment scale for adverse events in non-small cell lung carcinoma patients treated with platinum and pemetrexed doublet chemotherapy

  2021cites this paper